Medical News

RSS

The egg makes sure that sperm don't get too old

In contrast to women, men are fertile throughout life, but research at the Sahlgrenska Academy, University of Gothenburg, Sweden, has now shown that a fertilising sperm can get help from the egg to rejuvenate. The result is an important step towards future stem cell therapy.

25 Mar 2009

New approach to prostate cancer detection - Sarcosine may distinguish between slow-growing and aggressive prostate cancers

On Friday 20 March, US researcher Dr. Chris Beecher from the University of Michigan gave a well attended lecture about sarcosine, an N-methyl derivative of the amino acid glycine, at the 24th Annual EAU Congress in Stockholm, Sweden.

25 Mar 2009

Researchers decipher blood stem cell attachment, communication

Researchers at the National Institutes of Health have deciphered a key sequence of events governing whether the stem cells that produce red and white blood cells remain anchored to the bone marrow, or migrate into the circulatory system.

25 Mar 2009

Rockefeller neuroscientist applies basic science to health care reform

A self-described "molecular sociologist" is extending his basic research to the national policy debate on health care reform. Bruce McEwen, head of the Laboratory of Neuroendocrinology, led a panel of scientific experts last month at the Institute of Medicine's Summit on Integrative Medicine and the Health of the Public. The Institute is the most prominent independent medical advisory board in the country and will release a report from the conference in November, as Congress is likely to be considering major health care legislation.

25 Mar 2009

Effect of neighborhood context and smoking prevalence among Asian Americans

Does the neighborhood where you live play a role in whether you become a smoker?

24 Mar 2009

Discovery of a protein link to wound healing

Diabetes and eczema may appear to be two completely unrelated diseases.

24 Mar 2009

Sodas increase risk for coronary heart disease

Regular consumption of sugary beverages such as soda put women at a higher risk for coronary heart disease.

24 Mar 2009

Study helps identify college drinkers at risk for adult alcohol abuse

College students who are problem drinkers using alcohol to cope with personal problems and boost self-confidence are more likely to continue excessive drinking into adulthood, a recent study suggests.

24 Mar 2009

Diabetic retinopathy more prevalent in South Asians and occurs earlier

South Asians with type 2 diabetes are significantly more at risk of losing their eyesight and losing it at an earlier age, compared to White Europeans with the same condition.

24 Mar 2009

Single embryo transfer is the cheapest and most effective strategy for assisted reproduction

Transferring single embryos to women's wombs over several assisted reproduction cycles that use both fresh and frozen embryos is more effective and cheaper than transferring two or more embryos at one time, according to data from the world's longest running series of patients who choose to have only one embryo implanted per cycle - elective single embryo transfer (eSET).

24 Mar 2009

Rexahn Pharmaceuticals starts phase II pancreatic cancer trial

Rexahn Pharmaceuticals, Inc. has announced that it has received FDA approval to begin Phase II trials for Archexin, the Company's leading cancer compound, for the treatment of pancreatic cancer.

24 Mar 2009

Non-invasive laser treatments becoming more popular

New trends reveal that laser technology is steering the future of the cosmetic surgery industry.

24 Mar 2009

Recently identified genetic heart disorder often deadly for young patients

A study that included young patients with a recently recognized rare type of cardiomyopathy (a disorder of the heart muscle) linked to a genetic mutation finds that progression of this disease may be rapid and often results in early death, according to a study in the March 25 issue of JAMA.

24 Mar 2009

Radius starts Ppase 2a trial of RAD1901 in menopausal hot flashes

Radius Health ("Radius") announced today that the first patient has been dosed in the company's proof-of-concept Phase 2a study of RAD1901, an investigational selective estrogen receptor modulator (SERM) undergoing clinical evaluation for treatment of vasomotor symptoms (menopausal hot flashes).

24 Mar 2009

Scientists develop new agents to fight superbugs

Experts from Queen's University Belfast have developed new agents to fight MRSA and other hospital-acquired infections that are resistant to antibiotics.

24 Mar 2009

Collaborative care intervention helps improve management of chronic pain

Patients with chronic pain who took part in a collaborative care intervention that included patient and clinician education and symptom monitoring and feedback to the primary care physician had improvements in pain-related disability and intensity, compared to usual care, according to a study in the March 25 issue of JAMA, the Journal of the American Medical Association.

24 Mar 2009

Fit women much less likely to die from breast cancer

Physically fit women are less likely to die from breast cancer, according to a study by researchers at the University of South Carolina Arnold School of Public Health.

24 Mar 2009

Perrigo receives FDA approval for Sulfacetamide Sodium Topical Suspension USP, 10% (Lotion)

Perrigo Company has announced that it has received final approval from the U.S. Food and Drug Administration to market Sulfacetamide Sodium Topical Suspension, 10% (Lotion).

24 Mar 2009

Ovarian cancers detected early may be less aggressive, questioning effectiveness of screening

The biology of ovarian cancers discovered at an early stage may render them slower growing and less likely to spread than more aggressive cancers, which typically are discovered in an advanced stage, according to a study led by investigators in the Duke Comprehensive Cancer Center.

24 Mar 2009

Orexo reports on efficacy study in allergic rhinitis with OX914

Orexo has reported clinical results from an experimental phase IIa safety and efficacy study in allergic rhinitis with OX914, the first compound in its Phosphodiesterase 4 (PDE4) inhibitor program.

24 Mar 2009